Medication-associated Depersonalization Symptoms: Report of Transient Depersonalization Symptoms Induced by Minocycline

  title={Medication-associated Depersonalization Symptoms: Report of Transient Depersonalization Symptoms Induced by Minocycline},
  author={Philip R. Cohen},
  journal={Southern Medical Journal},
  • Philip R. Cohen
  • Published 1 January 2004
  • Psychology, Medicine
  • Southern Medical Journal
Patients with depersonalization disorder experience episodes in which they have a feeling of detachment from themselves. Symptoms of depersonalization may occur in individuals who have other mental disorders, or who have various medical conditions, or who have taken certain medications. A woman developed depersonalization symptoms after initiation of minocycline therapy. Her symptoms ceased after treatment was stopped and recurred when she restarted the drug. Medications that have been… 

Minocycline-induced transient depersonalization: A case report

The case of a 37-year-old female diagnosed with perioral dermatitis treated with minocycline, who within 1 week suffered from severe depersonalization symptoms.

Depersonalization disorder

Greater understanding of the clinical characteristics of this disorder will improve the reliability of diagnosis and aid the development of neurobiological and psychological models for empirical testing.

Past and Future Explanations for Depersonalization and Derealization Disorder: A Role for Predictive Coding

Depersonalization (DP) and derealization (DR) refer to states of dissociation in which one feels a sense of alienation in relation to one’s self and environment, respectively. Whilst transient

Are there two qualitatively distinct forms of dissociation? A review and some clinical implications.

A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea

Adverse effects and drug–drug interactions observed with oral administration of minocycline are reviewed and this with topical minocyCline formulations recently approved or under development for effectively treating dermatological disorders with fewer adverse effects and less drug interaction are compared.

Neuronal and microglial mechanisms of neuropathic pain

It is proposed that activity-dependent neuronal plasticity is a key target for treatment in neuropathic pain and may modulate nociceptive transmission under pathological conditions.

First Reports of Adverse Drug Reactions (ADRs) in Recent Weeks

  • Medicine, Biology
    International Journal of Pharmaceutical Medicine
  • 2012
A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl.

Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor

The evidence is weighed whether minocycline is indeed a bona fide microglia inhibitor and how data generated with minocyCline should be interpreted.



Alcohol-induced depersonalization

The spectrum of organic depersonalization: a review plus four new cases.

The authors present 4 new cases of depersonalization in patients with an underlying organic condition, along with 47 cases from the literature in which the available information permits diagnosis of organic depersonality, and suggested left-sided temporal lobe dysfunction and anxiety are suggested as factors in the development of depERSONalization.

Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine

Depersonalization and agoraphobia associated with marijuana use.

  • C. Moran
  • Psychology, Medicine
    The British journal of medical psychology
  • 1986
The standard cognitive-behavioural treatment programme required modification to account for the intensity of the fear of depersonalization in the cases, and data obtained before and after treatment indicated the cases were slightly more severe than clinic patients.

Prolonged depersonalization after marijuana use.

  • H. Szymanski
  • Psychology, Medicine
    The American journal of psychiatry
  • 1981
These cases suggest that after the patients had experienced depersonalization, external stressors and intrapsychic factors may have contributed to its continued use as a defense mechanism after marijuana use.

Feeling unreal: 30 cases of DSM-III-R depersonalization disorder.

This study supports the conceptualization of depersonalization disorder as a distinct disorder with a characteristic course that is independent of mood, anxiety, and personality symptoms, and suggests a subtle relationship may exist between childhood trauma and depersonALization disorder that merits further investigation.

Depersonalization after marijuana smoking

The dissociative disorders. Rarely considered and underdiagnosed.

  • P. Coons
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 1998